Cargando…
Orai1 as a potential “fits-all approach” therapeutic target for the treatment of DMD
Obliterating skeletal muscle Orai1 expression improves muscle pathology in the mdx mouse model of DMD—could Orai1 emerge as a potential drug target?
Autores principales: | Cheng, Arthur J., von Walden, Ferdinand, Lanner, Johanna T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Rockefeller University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9827522/ https://www.ncbi.nlm.nih.gov/pubmed/36595663 http://dx.doi.org/10.1085/jgp.202213224 |
Ejemplares similares
-
A Potential New Therapeutic Approach to DMD: PKC Theta Inhibition
por: Marques, Maria Julia
Publicado: (2017) -
The exquisitely cooperative nature of Orai1 channel activation
por: Yeung, Priscilla See-Wai, et al.
Publicado: (2018) -
Commentary: No one-size-fits-all approach to extracorporeal membrane oxygenation
por: Berger, Justin H., et al.
Publicado: (2021) -
Sphingomyelin, ORAI1 channels, and cellular Ca(2+) signaling
por: Hogan, Patrick G.
Publicado: (2015) -
Opioid-free anesthesia—caution for a one-size-fits-all approach
por: Gupta, Sushan, et al.
Publicado: (2020)